EUVIMEDEUVIMED entdecken
Crossref

Blood Patentability in Question: The Purview of Intellectual Property Law

Plabita Saikia

International Journal of Drug Delivery Technology · 02.06.2026 · 16 (43s)

DOI: 10.25258/ijddt.16.43s.28 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Plabita Saikia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The National Health Policy, 2002, directed the State to commit to universal health care through a "realistic" consideration of capacity (infrastructure and resources) as a key challenge toward making health care available to all. Within the human body, blood performs two primary functions in transportation of oxygen to various tissues and removal of carbon dioxide from the body. For considerable time, human kind is facing the problem of blood shortage and on the other side demand of blood increasing persistently. At the same time, Blood transfusion is a cornerstone of modern medical practice essential in almost every field of clinical practice either in emergency situations or as a necessary adjunct to modern and emerging Medicare. Role of Nanobiotechnology in this regard is commendable for helping healthcare sector by supplying substitute for the same. In the ages of Intellectual Property Rights, Laws regarding various issues of Blood deals with controversies and technical difficulties; even though getting various Patents regarding process and practices related to blood. As per The Patents Act, 1970 (39 of 1970); the section "Inventions - non-patentable" describes certain products and processes, which are not to be regarded as patentable inventions. The present communication deals with various related issues and discussions on the theme- whether blood comes under the purview of Intellectual property or not and various developments in IP regime of blood.

Zitieren

APA

Saikia, P. (2026). Blood Patentability in Question: The Purview of Intellectual Property Law. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.28

Vancouver

Saikia P. Blood Patentability in Question: The Purview of Intellectual Property Law. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.28

BibTeX
@article{Saikia2026,
  author = {Saikia, Plabita},
  title = {Blood Patentability in Question: The Purview of Intellectual Property Law},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {43s},
  doi = {10.25258/ijddt.16.43s.28}
}
Kostenlos starten →